Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2019

01/AQ.18.303 - Medicamentos antirretrovíricos

Contract value
€134,265.60
Signed on
3 April 2019
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5583470

PUBLISHED SUBJECT

01/AQ.18.303 - Medicamentos antirretrovíricos para o tratamento de infeção por VIH

WHO CONTRACTED

Parties involved

Place of performance
Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
GILEAD SCIENCES, LDA · Tax ID 503604704
Bidder
Mylan, Lda. · Tax ID 502248793
Bidder
GENERIS - FARMACEUTICA, S.A. · Tax ID 508107997

HOW MUCH AND WHEN

Values and timeline

Contract price
€134,265.60
Procedure base price
€134,841.20
Total effective price
Not reported on Portal BASE
Publication date
24 May 2019
Award date
3 April 2019
Signing date
3 April 2019
Performance period
273 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Melhor relação qualidade – preço
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3851720

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts